v3.25.2
Marketable Securities (Tables) - IKENA ONCOLOGY INC
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Summary of Marketable Securities
The following tables summarize the Company’s marketable securities (in thousands):
 
    
June 30, 2025
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Fair
Value
 
Corporate debt securities
     37,287        70        (5      37,352  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 37,287      $ 70      $ (5    $ 37,352  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2024
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Fair
Value
 
U.S. treasury securities
   $ 26,985      $ 19      $ —       $ 27,004  
Corporate debt securities
     57,940        84        (35      57,989  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 84,925      $ 103      $ (35    $ 84,993  
  
 
 
    
 
 
    
 
 
    
 
 
 
The following tables summarize the Company’s marketable securities (in
thousands
):
 
    
December 31, 2024
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Fair
Value
 
U.S. treasury securities
   $ 26,985      $ 19      $ —       $ 27,004  
Corporate debt securities
     57,940        84        (35      57,989  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 84,925      $ 103      $ (35    $ 84,993  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2023
 
    
Amortized
Cost
    
Gross
Unrealized
Gains
    
Gross
Unrealized
Losses
    
Fair
Value
 
Corporate debt securities
   $ 55,624      $ 27      $ (80    $ 55,571  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 55,624      $ 27      $ (80    $ 55,571  
  
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Fair Value of Available-for-Sale Securities By Contractual Maturity The following table summarizes the fair value of the Company’s
available-for-sale
securities by contractual maturity (in thousands):
 
    
June 30, 2025
 
Due in one year or less
   $ 21,706  
Due after one year through two years
     15,646  
  
 
 
 
Total
   $ 37,352  
  
 
 
 
The following table summarizes the fair value of the Company’s
available-for-sale
securities by contractual maturity (in thousands):
 
    
December 31,
2024
 
Due in one year or less
   $ 70,636  
Due after one year through two years
     14,357  
  
 
 
 
Total
   $ 84,993